Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2005 Sep 2;60(11):962–966. doi: 10.1136/thx.2005.041004

Chlamydophilapneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases

N Teig 1, A Anders 1, C Schmidt 1, C Rieger 1, S Gatermann 1
PMCID: PMC1747249  PMID: 16143584

Abstract

Background: Persistent infection with Mycoplasma pneumoniae and Chlamydophila pneumoniae has been implicated in the progression or induction of asthma and chronic obstructive pulmonary disease. Evidence for this hypothesis has been obtained in adults either by serological methods or by direct pathogen detection using invasive procedures.

Methods: We investigated nasal brush specimens and induced sputum from 38 children with stable chronic lung disease (asthma, n = 26; chronic bronchitis n = 12) and from 42 healthy controls for the presence of M pneumoniae or Cpneumoniae DNA by polymerase chain reaction (PCR) using nested primers.

Results: None of the controls but 23.6% and 10.5% of the children with lung disease had positive PCR for C pneumoniae (p = 0.001) and M pneumoniae (p = 0.044) respectively. Significantly more children with non-atopic asthma than with atopic asthma were positive for C pneumoniae or M pneumoniae (4/8 v 1/18; p = 0.018). There were no unwanted side effects from sputum induction. No correlation was found between detection of Chlamydophila and severity of lung disease. Colonisation with both organisms had occurred before adulthood in a significant proportion of children with stable chronic lung diseases.

Conclusion: Combining nasal brush specimens with induced sputum may be a useful non-invasive method for studying the role of C pneumoniae and M pneumoniae infection in children with different chronic lung diseases.

Full Text

The Full Text of this article is available as a PDF (92.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abele-Horn M., Franck W., Busch U., Nitschko H., Roos R., Heesemann J. Transverse myelitis associated with Mycoplasma pneumoniae infection. Clin Infect Dis. 1998 Apr;26(4):909–912. doi: 10.1086/513919. [DOI] [PubMed] [Google Scholar]
  2. Bernet C., Garret M., de Barbeyrac B., Bebear C., Bonnet J. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol. 1989 Nov;27(11):2492–2496. doi: 10.1128/jcm.27.11.2492-2496.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biscione G. L., Corne J., Chauhan A. J., Johnston S. L. Increased frequency of detection of Chlamydophila pneumoniae in asthma. Eur Respir J. 2004 Nov;24(5):745–749. doi: 10.1183/09031936.04.00049004. [DOI] [PubMed] [Google Scholar]
  4. Black P. N., Blasi F., Jenkins C. R., Scicchitano R., Mills G. D., Rubinfeld A. R., Ruffin R. E., Mullins P. R., Dangain J., Cooper B. C. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med. 2001 Aug 15;164(4):536–541. doi: 10.1164/ajrccm.164.4.2011040. [DOI] [PubMed] [Google Scholar]
  5. Blasi F., Damato S., Cosentini R., Tarsia P., Raccanelli R., Centanni S., Allegra L., Chlamydia InterAction with COPD (CIAC) Study Group Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax. 2002 Aug;57(8):672–676. doi: 10.1136/thorax.57.8.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boman J., Söderberg S., Forsberg J., Birgander L. S., Allard A., Persson K., Jidell E., Kumlin U., Juto P., Waldenström A. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis. 1998 Jul;178(1):274–277. doi: 10.1086/517452. [DOI] [PubMed] [Google Scholar]
  7. Byrne G. I., Ouellette S. P., Wang Z., Rao J. P., Lu L., Beatty W. L., Hudson A. P. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun. 2001 Sep;69(9):5423–5429. doi: 10.1128/IAI.69.9.5423-5429.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Campbell L. A., Perez Melgosa M., Hamilton D. J., Kuo C. C., Grayston J. T. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol. 1992 Feb;30(2):434–439. doi: 10.1128/jcm.30.2.434-439.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cunningham A. F., Johnston S. L., Julious S. A., Lampe F. C., Ward M. E. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 1998 Feb;11(2):345–349. doi: 10.1183/09031936.98.11020345. [DOI] [PubMed] [Google Scholar]
  10. Dallo S. F., Baseman J. B. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog. 2000 Nov;29(5):301–309. doi: 10.1006/mpat.2000.0395. [DOI] [PubMed] [Google Scholar]
  11. Dowell S. F., Peeling R. W., Boman J., Carlone G. M., Fields B. S., Guarner J., Hammerschlag M. R., Jackson L. A., Kuo C. C., Maass M. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis. 2001 Jul 20;33(4):492–503. doi: 10.1086/322632. [DOI] [PubMed] [Google Scholar]
  12. Emre U., Roblin P. M., Gelling M., Dumornay W., Rao M., Hammerschlag M. R., Schachter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med. 1994 Jul;148(7):727–732. doi: 10.1001/archpedi.1994.02170070065013. [DOI] [PubMed] [Google Scholar]
  13. Esposito S., Blasi F., Arosio C., Fioravanti L., Fagetti L., Droghetti R., Tarsia P., Allegra L., Principi N. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J. 2000 Dec;16(6):1142–1146. doi: 10.1034/j.1399-3003.2000.16f21.x. [DOI] [PubMed] [Google Scholar]
  14. Esposito Susanna, Droghetti Roberta, Bosis Samantha, Claut Laura, Marchisio Paola, Principi Nicola. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze. Pediatr Pulmonol. 2002 Aug;34(2):122–127. doi: 10.1002/ppul.10139. [DOI] [PubMed] [Google Scholar]
  15. Falck G., Gnarpe J., Gnarpe H. Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections. Pediatr Infect Dis J. 1997 Jun;16(6):549–554. doi: 10.1097/00006454-199706000-00003. [DOI] [PubMed] [Google Scholar]
  16. Fong I. W., Chiu B., Viira E., Jang D., Fong M. W., Peeling R., Mahony J. B. Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? Clin Diagn Lab Immunol. 1999 Nov;6(6):891–894. doi: 10.1128/cdli.6.6.891-894.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Freymuth F., Vabret A., Brouard J., Toutain F., Verdon R., Petitjean J., Gouarin S., Duhamel J. F., Guillois B. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol. 1999 Aug;13(3):131–139. doi: 10.1016/S1386-6532(99)00030-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gencay M., Rüdiger J. J., Tamm M., Solér M., Perruchoud A. P., Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med. 2001 Apr;163(5):1097–1100. doi: 10.1164/ajrccm.163.5.2003162. [DOI] [PubMed] [Google Scholar]
  19. Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., Wang S. P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990 Apr;161(4):618–625. doi: 10.1093/infdis/161.4.618. [DOI] [PubMed] [Google Scholar]
  20. Hahn D. L., Anttila T., Saikku P. Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect. 1996 Dec;117(3):513–517. doi: 10.1017/s0950268800059197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hammerschlag Margaret R. The intracellular life of chlamydiae. Semin Pediatr Infect Dis. 2002 Oct;13(4):239–248. doi: 10.1053/spid.2002.127201. [DOI] [PubMed] [Google Scholar]
  22. Heiskanen-Kosma T., Korppi M., Laurila A., Jokinen C., Kleemola M., Saikku P. Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study. Scand J Infect Dis. 1999;31(3):255–259. doi: 10.1080/00365549950163536. [DOI] [PubMed] [Google Scholar]
  23. Johnston S. L. Is Chlamydia pneumoniae important in asthma? The first controlled trial of therapy leaves the question unanswered. Am J Respir Crit Care Med. 2001 Aug 15;164(4):513–514. doi: 10.1164/ajrccm.164.4.2105129a. [DOI] [PubMed] [Google Scholar]
  24. Kalayoglu Murat V., Libby Peter, Byrne Gerald I. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002 Dec 4;288(21):2724–2731. doi: 10.1001/jama.288.21.2724. [DOI] [PubMed] [Google Scholar]
  25. Kern D. G., Neill M. A., Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest. 1993 Jul;104(1):208–213. doi: 10.1378/chest.104.1.208. [DOI] [PubMed] [Google Scholar]
  26. Kraft Monica, Cassell Gail H., Pak Juno, Martin Richard J. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest. 2002 Jun;121(6):1782–1788. doi: 10.1378/chest.121.6.1782. [DOI] [PubMed] [Google Scholar]
  27. Lieberman D., Lieberman D., Ben-Yaakov M., Lazarovich Z., Hoffman S., Ohana B., Friedman M. G., Dvoskin B., Leinonen M., Boldur I. Infectious etiologies in acute exacerbation of COPD. Diagn Microbiol Infect Dis. 2001 Jul;40(3):95–102. doi: 10.1016/s0732-8893(01)00255-3. [DOI] [PubMed] [Google Scholar]
  28. Maass M., Krause E., Engel P. M., Krüger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology. 1997 Aug;48(8):699–706. doi: 10.1177/000331979704800805. [DOI] [PubMed] [Google Scholar]
  29. Martin R. J., Kraft M., Chu H. W., Berns E. A., Cassell G. H. A link between chronic asthma and chronic infection. J Allergy Clin Immunol. 2001 Apr;107(4):595–601. doi: 10.1067/mai.2001.113563. [DOI] [PubMed] [Google Scholar]
  30. Mills G. D., Lindeman J. A., Fawcett J. P., Herbison G. P., Sears M. R. Chlamydia pneumoniae serological status is not associated with asthma in children or young adults. Int J Epidemiol. 2000 Apr;29(2):280–284. doi: 10.1093/ije/29.2.280. [DOI] [PubMed] [Google Scholar]
  31. Miyashita N., Kubota Y., Nakajima M., Niki Y., Kawane H., Matsushima T. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol. 1998 May;80(5):405–409. doi: 10.1016/S1081-1206(10)62992-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Miyashita N., Niki Y., Nakajima M., Fukano H., Matsushima T. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest. 2001 May;119(5):1416–1419. doi: 10.1378/chest.119.5.1416. [DOI] [PubMed] [Google Scholar]
  33. Miyashita Naoyuki, Fukano Hiroshi, Yoshida Koichiro, Niki Yoshihito, Matsushima Toshiharu. Chlamydia pneumoniae infection in adult patients with persistent cough. J Med Microbiol. 2003 Mar;52(Pt 3):265–269. doi: 10.1099/jmm.0.04986-0. [DOI] [PubMed] [Google Scholar]
  34. Moazed T. C., Kuo C. C., Grayston J. T., Campbell L. A. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis. 1998 May;177(5):1322–1325. doi: 10.1086/515280. [DOI] [PubMed] [Google Scholar]
  35. Munger Kassandra L., Peeling Rosanna W., Hernán Miguel A., Chasan-Taber Lisa, Olek Michael J., Hankinson Susan E., Hunter David, Ascherio Alberto. Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology. 2003 Mar;14(2):141–147. doi: 10.1097/01.EDE.0000050699.23957.8E. [DOI] [PubMed] [Google Scholar]
  36. Saikku P., Laitinen K., Leinonen M. Animal models for Chlamydia pneumoniae infection. Atherosclerosis. 1998 Oct;140 (Suppl 1):S17–S19. doi: 10.1016/s0021-9150(98)00115-4. [DOI] [PubMed] [Google Scholar]
  37. Schmidt S. M., Müller C. E., Bruns R., Wiersbitzky S. K. Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children. Pediatr Allergy Immunol. 2001 Oct;12(5):257–265. doi: 10.1034/j.1399-3038.2001.00042.x. [DOI] [PubMed] [Google Scholar]
  38. Smieja Marek, Leigh Richard, Petrich Astrid, Chong Sylvia, Kamada Dennis, Hargreave Frederick E., Goldsmith Charles H., Chernesky Max, Mahony James B. Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients. BMC Infect Dis. 2002 Jul 5;2:12–12. doi: 10.1186/1471-2334-2-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tondella Maria Lucia C., Talkington Deborah F., Holloway Brian P., Dowell Scott F., Cowley Karyn, Soriano-Gabarro Montse, Elkind Mitchell S., Fields Barry S. Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol. 2002 Feb;40(2):575–583. doi: 10.1128/JCM.40.2.575-583.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Villareal Cheryl, Whittum-Hudson Judith A., Hudson Alan P. Persistent Chlamydiae and chronic arthritis. Arthritis Res. 2001 Oct 8;4(1):5–9. doi: 10.1186/ar382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Volanen Iina, Vainionpä Raija, Ilonen Jorma, Markula Perttu, Kallio Katariina, Kaitosaari Tuuli, Helenius Hans, Simell Olli. A prospective study of Chlamydia pneumoniae antibodies in children between 7 months and 8 years of age. Scand J Infect Dis. 2003;35(8):471–477. doi: 10.1080/00365540310013351. [DOI] [PubMed] [Google Scholar]
  42. Von Hertzen L., Alakärppä H., Koskinen R., Liippo K., Surcel H. M., Leinonen M., Saikku P. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect. 1997 Apr;118(2):155–164. doi: 10.1017/s095026889600725x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Von Hertzen L., Töyrylä M., Gimishanov A., Bloigu A., Leinonen M., Saikku P., Haahtela T. Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy. 1999 Apr;29(4):522–528. doi: 10.1046/j.1365-2222.1999.00504.x. [DOI] [PubMed] [Google Scholar]
  44. Waring A. L., Halse T. A., Csiza C. K., Carlyn C. J., Arruda Musser K., Limberger R. J. Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State. J Clin Microbiol. 2001 Apr;39(4):1385–1390. doi: 10.1128/JCM.39.4.1385-1390.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wu L., Skinner S. J., Lambie N., Vuletic J. C., Blasi F., Black P. N. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1148–1151. doi: 10.1164/ajrccm.162.3.9912134. [DOI] [PubMed] [Google Scholar]
  46. ten Brinke A., van Dissel J. T., Sterk P. J., Zwinderman A. H., Rabe K. F., Bel E. H. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol. 2001 Mar;107(3):449–454. doi: 10.1067/mai.2001.113047. [DOI] [PubMed] [Google Scholar]
  47. von Hertzen L., Isoaho R., Leinonen M., Koskinen R., Laippala P., Töyrylä M., Kivelä S. L., Saikku P. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol. 1996 Jun;25(3):658–664. doi: 10.1093/ije/25.3.658. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES